Literature DB >> 16133942

Guanosine enhances glutamate transport capacity in brain cortical slices.

Marcos Emílio Frizzo1, Fábio Duarte Schwalm, Juliana Karl Frizzo, Félix Antunes Soares, Diogo Onofre Souza.   

Abstract

1. The effect of guanosine on L-[3H] glutamate uptake was investigated in brain cortical slices within physio-pathological range of glutamate(1-1000 microM). In these conditions, glutamate uptake was significantly enhanced in slices treated with 100 microM guanosine only at 100 and 300 microM glutamate (44 and 52%, respectively). 2. Evaluation of kinetic parameters showed that guanosine affected significantly only uptake Vmax (23%). 3. The guanosine withdrawal did not abolish its significant effect on glutamate uptake when 100 or 300 microM glutamate were used (an increase of 66 and 35%, respectively). 4. These results support the hypothesis of a protective role for guanosine during excitotoxic conditions when glutamate levels are enhanced (e.g. brain ischemia and seizures), possibly by activating glutamate uptake. Moreover, our results may contribute to understand the antiexcitotoxic mechanism of guanosine on glutamate transport, giving new information concerning its mechanism of action.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16133942     DOI: 10.1007/s10571-005-4939-5

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  32 in total

Review 1.  Separate mechanisms for short- and long-term memory.

Authors:  I Izquierdo; J H Medina; M R Vianna; L A Izquierdo; D M Barros
Journal:  Behav Brain Res       Date:  1999-08       Impact factor: 3.332

Review 2.  Glutamate receptors in the mammalian central nervous system.

Authors:  S Ozawa; H Kamiya; K Tsuzuki
Journal:  Prog Neurobiol       Date:  1998-04       Impact factor: 11.685

Review 3.  Role of adenosine as a modulator of synaptic activity in the central nervous system.

Authors:  J M Brundege; T V Dunwiddie
Journal:  Adv Pharmacol       Date:  1997

4.  Guanosine and GMP prevent seizures induced by quinolinic acid in mice.

Authors:  A P Schmidt; D R Lara; J de Faria Maraschin; A da Silveira Perla; D Onofre Souza
Journal:  Brain Res       Date:  2000-05-02       Impact factor: 3.252

5.  Sustained depolarisation induces changes in the extracellular concentrations of purine and pyrimidine nucleosides in the rat thalamus.

Authors:  A Dobolyi; A Reichart; T Szikra; G Nyitrai; K A Kékesi; G Juhász
Journal:  Neurochem Int       Date:  2000-07       Impact factor: 3.921

6.  Effect of orally administered guanosine on seizures and death induced by glutamatergic agents.

Authors:  D R Lara; A P Schmidt; M E Frizzo; J S Burgos; G Ramírez; D O Souza
Journal:  Brain Res       Date:  2001-09-07       Impact factor: 3.252

Review 7.  Bioenergetics and glutamate excitotoxicity.

Authors:  J G Greene; J T Greenamyre
Journal:  Prog Neurobiol       Date:  1996-04       Impact factor: 11.685

8.  Chronically administered guanosine is anticonvulsant, amnesic and anxiolytic in mice.

Authors:  Elsa Regina Vinadé; André Prato Schmidt; Marcos Emílio Santos Frizzo; Ivan Izquierdo; Elaine Elisabetsky; Diogo Onofre Souza
Journal:  Brain Res       Date:  2003-07-04       Impact factor: 3.252

9.  Quinolinic acid promotes seizures and decreases glutamate uptake in young rats: reversal by orally administered guanosine.

Authors:  Diogo Losch de Oliveira; Joel Felipe Horn; Juliana Moura Rodrigues; Marcos E S Frizzo; Emílio Moriguchi; Diogo Onofre Souza; Susana Wofchuk
Journal:  Brain Res       Date:  2004-08-20       Impact factor: 3.252

10.  Anticonvulsant effect of GMP depends on its conversion to guanosine.

Authors:  Félix A Soares; André P Schmidt; Marcelo Farina; Marcos E S Frizzo; Rejane G Tavares; Luís V C Portela; Diogo R Lara; Diogo O Souza
Journal:  Brain Res       Date:  2004-04-16       Impact factor: 3.252

View more
  8 in total

1.  Effects of chronic guanosine treatment on hippocampal damage and cognitive impairment of rats submitted to chronic cerebral hypoperfusion.

Authors:  Marcelo Ganzella; Enderson Dias Alves de Oliveira; Daniel Diniz Comassetto; Fernanda Cechetti; Victor Hermes Cereser; Júlia Dubois Moreira; Gisele Hansel; Roberto Farina Almeida; Denise Barbosa Ramos; Yanier Nuñes Figueredo; Debora Guerini Souza; Jean Pierre Oses; Paulo Valdeci Worm; Matilde Achaval; Carlos Alexandre Netto; Diogo Onofre Souza
Journal:  Neurol Sci       Date:  2011-12-14       Impact factor: 3.307

2.  Neuroprotective agents: is effective on toxicity in glial cells?

Authors:  Taner Dagci; Ozlem Yilmaz; Dilek Taskiran; Gonul Peker
Journal:  Cell Mol Neurobiol       Date:  2006-06-07       Impact factor: 5.046

3.  Enhanced subcortical spreading depression in familial hemiplegic migraine type 1 mutant mice.

Authors:  Katharina Eikermann-Haerter; Izumi Yuzawa; Tao Qin; Yumei Wang; Kwangyeol Baek; Young Ro Kim; Ulrike Hoffmann; Ergin Dilekoz; Christian Waeber; Michel D Ferrari; Arn M J M van den Maagdenberg; Michael A Moskowitz; Cenk Ayata
Journal:  J Neurosci       Date:  2011-04-13       Impact factor: 6.167

4.  Effects of 3 weeks GMP oral administration on glutamatergic parameters in mice neocortex.

Authors:  Marcelo Ganzella; Julia Dubois Moreira; Roberto Farina Almeida; Ana Elisa Böhmer; Jonas Alex Morales Saute; Silvia Holmseth; Diogo Onofre Souza
Journal:  Purinergic Signal       Date:  2011-09-01       Impact factor: 3.765

Review 5.  Neuroprotective Effects of Guanosine in Ischemic Stroke-Small Steps towards Effective Therapy.

Authors:  Karol Chojnowski; Mikolaj Opielka; Wojciech Nazar; Przemyslaw Kowianski; Ryszard T Smolenski
Journal:  Int J Mol Sci       Date:  2021-06-27       Impact factor: 5.923

6.  Neuroprotective Effects of the Glutamate Transporter Activator (R)-(-)-5-methyl-1-nicotinoyl-2-pyrazoline (MS-153) following Traumatic Brain Injury in the Adult Rat.

Authors:  Andréia Cristina Fontana; Douglas P Fox; Argie Zoubroulis; Ole Valente Mortensen; Ramesh Raghupathi
Journal:  J Neurotrauma       Date:  2015-09-24       Impact factor: 5.269

Review 7.  Novel Targets for Fast Antidepressant Responses: Possible Role of Endogenous Neuromodulators.

Authors:  Anderson Camargo; Ana Lúcia S Rodrigues
Journal:  Chronic Stress (Thousand Oaks)       Date:  2019-06-26

Review 8.  The Guanine-Based Purinergic System: The Tale of An Orphan Neuromodulation.

Authors:  Valentina Di Liberto; Giuseppa Mudò; Roberta Garozzo; Monica Frinchi; Víctor Fernandez-Dueñas; Patrizia Di Iorio; Renata Ciccarelli; Francesco Caciagli; Daniele F Condorelli; Francisco Ciruela; Natale Belluardo
Journal:  Front Pharmacol       Date:  2016-06-17       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.